Cite
Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation.
MLA
Müller, Joachim, et al. “Proteomic Characterization of Toxoplasma Gondii ME49 Derived Strains Resistant to the Artemisinin Derivatives Artemiside and Artemisone Implies Potential Mode of Action Independent of ROS Formation.” International Journal for Parasitology. Drugs and Drug Resistance, vol. 21, Apr. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1016/j.ijpddr.2022.11.005.
APA
Müller, J., Schlange, C., Heller, M., Uldry, A.-C., Braga-Lagache, S., Haynes, R. K., & Hemphill, A. (2023). Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation. International Journal for Parasitology. Drugs and Drug Resistance, 21, 1–12. https://doi.org/10.1016/j.ijpddr.2022.11.005
Chicago
Müller, Joachim, Carling Schlange, Manfred Heller, Anne-Christine Uldry, Sophie Braga-Lagache, Richard K Haynes, and Andrew Hemphill. 2023. “Proteomic Characterization of Toxoplasma Gondii ME49 Derived Strains Resistant to the Artemisinin Derivatives Artemiside and Artemisone Implies Potential Mode of Action Independent of ROS Formation.” International Journal for Parasitology. Drugs and Drug Resistance 21 (April): 1–12. doi:10.1016/j.ijpddr.2022.11.005.